The Levels of Anti-SARS-CoV-2 Spike Protein IgG Antibodies Before and After the Third Dose of Vaccination Against COVID-19
Małgorzata Łysek-Gładysińska,1 Magdalena Starz,2 Agnieszka Borowiec-Sęk,2 Iwona Sufin,2 Anna Wieczorek,1 Magdalena Chrapek,3 Dorota Zarębska-Michaluk,4 Patrycja Sufin,2 Stanisław Głuszek,4 Wioletta Adamus-Bia&l...
Main Authors: | Łysek-Gładysińska M, Starz M, Borowiec-Sęk A, Sufin I, Wieczorek A, Chrapek M, Zarębska-Michaluk D, Sufin P, Głuszek S, Adamus-Białek W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/the-levels-of-anti-sars-cov-2-spike-protein-igg-antibodies-before-and--peer-reviewed-fulltext-article-JIR |
Similar Items
-
The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19
by: Michał Majchrzak, et al.
Published: (2024-03-01) -
Breastfeeding and Prevalence of Metabolic Syndrome among Perimenopausal Women
by: Edyta Suliga, et al.
Published: (2020-09-01) -
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
by: Maika Takahashi, et al.
Published: (2022-09-01) -
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
by: Jennifer Serwanga, et al.
Published: (2023-03-01) -
Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
by: Jason K. Iles, et al.
Published: (2022-05-01)